Propofol pretreatment induced place preference and self-administration of the tiletamine-zolazepam combination: Implication on drug of abuse substitution

American Journal of Drug and Alcohol Abuse

Volumn 40, Issue 4, 2014, Pages 321-326

  De La Peña, June Bryan ^a   Ahsan, Hafiz Muhammad ^a   Dela Peña, Irene Joy ^a   Park, Hyun Bin ^a   Kim, Hee Jin ^a   Sohn, Aeree ^a   Kim, Yun Tai ^b   Cheong, Jae Hoon ^a  

^a Sahmyook University   (South Korea)

^b CHA Stem Cell Institute   (South Korea)

Author keywords

Conditioned place preference; Propofol; Self administration; Tiletamine; Zolazepam; Zoletil

Indexed keywords

PROPOFOL; SODIUM CHLORIDE; TILETAMINE PLUS ZOLAZEPAM; ANESTHETIC AGENT; DRUG COMBINATION; TILETAMINE; TILETAMINE, ZOLAZEPAM DRUG COMBINATION; ZOLAZEPAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; MALE; MULTIPLE DRUG ABUSE; NONHUMAN; PLACE PREFERENCE; PREMEDICATION; RAT; REINFORCEMENT; REWARD; SELF ADMINISTRATION TEST; ANIMAL; DRUG COMBINATION; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; LEARNING; SPRAGUE DAWLEY RAT;

ANESTHETICS; ANIMALS; ASSOCIATION LEARNING; CONDITIONING, OPERANT; DRUG COMBINATIONS; MALE; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; TILETAMINE; ZOLAZEPAM;

EID: 84903435216     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2014.920850     Document Type: Article

References (27)

1. Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 2008;14: 95-106.
2. Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila) 2010;48:165-170.
3. Hartle A, Malhotra S. The safety of propofol. BMJ 2009;339: B4024.
4. Lee S, Lee MS, Kim YA, Ahn W, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med 2010;34:101-107.
5. Han E, Jung S, Baeck S, Lee S, Chung H. Deaths from recreational use of propofol in Korea. Forensic Sci Int 2013;233:333-337.
6. Kim D-K. Propofol use for sedation or sedation for propofol use? J Anesth 2012;26:289-291.
7. Kim R. Illegal drug use rises steeply. Available from: Http://www.koreatimes.co.kr/www/news/nation/2011/09/117-95135.html 2011 [last accessed 14 Feb 2013]
8. Virbac. Guidebook of Anesthetic Protocols-Cats. Available from: Http://www.virbac.cz/zoletil-guide-cats.html [last accessed 14 Feb 2014]
9. Redmond AH, Herman MI. Ingestion of Telazol-, a veterinary anaesthetic, by a 16 year-old male. Clin Intensive Care 2002;13: 139-142.
10. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: A review of the literature. Fundam Clin Pharmacol 2007; 21:459-466.
11. Lee YK, Kang IG, Park CS, Heo SJ, Chai YS, Park SS, Lee JK, et al. A case of mental change in a patient who received a Zoletil injection. J Korean Soc Clin Toxicol 2013;11:23-27.
12. de la Pena JB, Lee HC, de la Pena IC, Woo TS, Yoon SY, Lee HL, Han JS, et al. Rewarding and reinforcing effects of the NMDA receptor antagonist- benzodiazepine combination, Zoletil-: Difference between acute and repeated exposure. Behav Brain Res 2012; 233:434-442.
13. de la Pena JB, Yoon SY, de la Pena IC, Lee HL, de la IPIJ, Cheong JH. Pre-exposure to related substances induced place preference and self-Administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil-. Behav Pharmacol 2012;24:20-28.
14. de la Peña JBI, Lee HL, Shin CY, Sohn AR, Cheong JH. Pre-exposure to ethanol, but not to caffeine and nicotine, induced place preference and self-Administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil-. Pharmacol Biochem Behav 2013;110:231-237.
15. Gardner EL. What we have learned about addiction from animal models of drug self-Administration. Am J Addict 2000;9:285-313.
16. Bardo MT, Bevins RA. Conditioned place preference: What does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 2000;153:31-43.
17. Pain L, Oberling P, Sandner G, Di Scala G. Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology 1996;85:121-128.
18. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Polydrug use. Annual report of the EMCDDA 2002.
19. Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: The relationship between perceived functions and intentions. Addiction 1999;94:1043-1050.
20. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Polydrug use: Patterns and responses. Annual Report of the EMCDDA 2009.
21. Cha HJ, Cha J-H, Cho H-Y, Chung E-Y, Kwon K-J, Lee JY, Jeong H-S, et al. Dependence potential of propofol: Behavioral pharmacology in rodents. Biomol Ther (Seoul) 2012;20:234-238.
22. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the g-Aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998;53:530-538.
23. Krasowski MD, Jenkins A, Flood P, Kung AY, Hopfinger AJ, Harrison NL. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of g-Aminobutyric acid (GABA) current at the GABAA receptor but not with lipid solubility. J Pharmacol Exp Ther 2001;297:338-351.
24. Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2, 6 di-isopropylphenol) of the N-methyl-D-Aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995;116:1761-1768.
25. Roberge C, Beaudet M-J, Anderson A. GABAA central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A. Biochem Pharmacol 2004;68:1383-1389.
26. UNODC. World Drug Report 2013. United Nations publication 2013; Sales No. E.13.XI.6.
27. EMCDDA-Europol. New drugs in Europe, 2012. Annual Report of the European Monitoring Centre for Drugs and Drug Addiction and European Police Office 2013.